Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by UMC Utrecht
King's College London
Technische Universität München
University of Manchester
Ludwig-Maximilians - University of Munich
Information provided by (Responsible Party):
Rene Kahn, UMC Utrecht Identifier:
First received: October 20, 2010
Last updated: July 16, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2016
  Estimated Primary Completion Date: January 2016 (Final data collection date for primary outcome measure)